News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Metabolon Announces Quantose IR Test Launched In Mexico To Help Prevent Type 2 Diabetes



6/5/2014 9:04:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

RESEARCH TRIANGLE PARK, N.C., June 4, 2014 (GLOBE NEWSWIRE) -- Metabolon, a global leader in metabolomics, announced today that its Quantose IR™ prediabetes test is now available to physicians in Mexico through PATIA Biopharma, its commercial partner there. In addition, PATIA and its affiliates will be using Quantose IR in two large-scale studies to test up to three million adults and teenagers in Mexico who are overweight or obese and/or have a family history of diabetes. It is estimated that one out of every five adults in Mexico has prediabetes, a condition that often progresses to type 2 diabetes if left untreated. Early detection is crucial, because prediabetes can be reversed with lifestyle changes and treatment.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Metabolon
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES